LifeMD, Inc. — Director's Dealing 2017

Nov 14, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Immudyne, Inc. (IMMD)
CIK: 0000948320
Period of Report: 2017-10-16

Reporting Person: Borenstein Michael (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.01	217390	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrant	$0.4	2020-04-23	Common Stock, par value $0.01 (108696)		Indirect

Footnotes

F1: Mr. Bornstein is the holder of a 50% equity interest in Pilaris Laboratories, LLC. The reporting person disclaims beneficial ownership of the reported securities held by such LLC except to the extent of his pecuniary interest therein.